InvestorsHub Logo
Followers 37
Posts 3775
Boards Moderated 0
Alias Born 06/07/2009

Re: None

Tuesday, 10/20/2020 6:22:04 PM

Tuesday, October 20, 2020 6:22:04 PM

Post# of 3052

On October 20, 2020, the Company received a letter from the staff of the Fort Worth Regional Office of the U.S. Securities and Exchange Commission (the “SEC”) informing the Company that the SEC staff had concluded the previously announced informal, fact-finding inquiry relating to certain press releases issued by the Company in March 2020 regarding the BreathTest-1000™ lung disease screening device currently under development by the Company. The letter advised the Company that the SEC staff does not intend to recommend an enforcement action against the Company.



Very nice 8-K
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASTC News